Data from the Survey of Unmet Needs in Chronic Myeloid Leukemia (CML SUN) trial show that quality of life (QOL) and shared decision-making are priorities for patients, said Fabian Lang, MD, of Goethe University Hospital in Frankfurt, Germany.
Data from the Survey of Unmet Needs in Chronic Myeloid Leukemia (CML SUN) trial show that quality of life (QOL) and shared decision-making are priorities for patients, said Fabian Lang, MD, of Goethe University Hospital in Frankfurt, Germany.
Transcript
What are some of the main points that health care providers and health systems can take away from the CML SUN trial results?
The CML SUN trial showed that, for example, fatigue is a quite present problem in these patients, which we were not much aware of. So, this is something we've got to get a handle on, which is difficult to evaluate, difficult to treat, and difficult to talk about. And what we've also seen is that doctors are mainly focused on BCR-ABL levels, which means numbers, in order to conduct and treat the patients. But, on the other hand, patients are more focused on things like quality of life, daily problems, and they are mainly focused on that. It is something which is quite true across all line of therapies.
And in the end, we also found that most of the patients do not have the feeling that a shared decision-making is taking place. So doctors tend to to tell the patients how therapy works and do not propose multiple therapies or discuss the therapies with the patients, and this is also something which comes through over all lines of therapy.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Transforming Health Care: Insights From Industry Leaders on Health Equity and Policy
September 25th 2023At the National Comprehensive Cancer Network Oncology Policy Summit, prominent figures in the health care industry from diverse organizations emphasized a commitment to advancing health equity and addressing pressing social and health disparities.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
Support and Follow-Up Are Needed to Combat Distress in Lymphoma
September 21st 2023Several discrepancies in care must be considered to properly address psychological needs in patients with lymphoma, including patient/doctor communication, information provision, and applying distress guidelines.
Read More
New CMS Models Target Transformation to Address Need for Health Equity
September 21st 2023"CMS cannot do this alone. We have to do this in partnership. So really thinking about providers and beneficiaries and how we do this together," Ellen Lukens, MPH, Center for Medicare and Medicaid Innovation, explained.
Read More
2 Clarke Drive
Cranbury, NJ 08512